Clinical trials
Phase 1/2 Lung Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Daiichi Sankyo | 1 |
| GlaxoSmithKline | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Novartis Pharmaceuticals | 1 |
| Turning Point Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Neoplasms | 4 |
| Thyroid Neoplasms | 4 |
| Bronchial Neoplasms | 3 |
| Carcinoma, Bronchogenic | 3 |
| Colonic Neoplasms | 3 |
| Endocrine Gland Neoplasms | 3 |
| Endocrine System Diseases | 3 |
| Head and Neck Neoplasms | 3 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.